Class information for:
Level 1: OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8498 1179 26.6 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
126 23061 TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OKT3 Author keyword 32 42% 5% 58
2 MUROMONAB CD3 Author keyword 8 48% 1% 12
3 ANTI OKT3 ANTIBODIES Author keyword 6 100% 0% 4
4 ANTI CD3 Author keyword 4 20% 1% 16
5 OTELIXIZUMAB Author keyword 3 57% 0% 4
6 OKT3 ANTIBODY Author keyword 3 100% 0% 3
7 UNITE 580 Address 2 44% 0% 4
8 ORTHOCLONE OKT3 Author keyword 2 67% 0% 2
9 CD3 ANTIBODIES Author keyword 2 50% 0% 3
10 MINI YCD3 Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 OKT3 32 42% 5% 58 Search OKT3 Search OKT3
2 MUROMONAB CD3 8 48% 1% 12 Search MUROMONAB+CD3 Search MUROMONAB+CD3
3 ANTI OKT3 ANTIBODIES 6 100% 0% 4 Search ANTI+OKT3+ANTIBODIES Search ANTI+OKT3+ANTIBODIES
4 ANTI CD3 4 20% 1% 16 Search ANTI+CD3 Search ANTI+CD3
5 OTELIXIZUMAB 3 57% 0% 4 Search OTELIXIZUMAB Search OTELIXIZUMAB
6 OKT3 ANTIBODY 3 100% 0% 3 Search OKT3+ANTIBODY Search OKT3+ANTIBODY
7 ORTHOCLONE OKT3 2 67% 0% 2 Search ORTHOCLONE+OKT3 Search ORTHOCLONE+OKT3
8 CD3 ANTIBODIES 2 50% 0% 3 Search CD3+ANTIBODIES Search CD3+ANTIBODIES
9 MINI YCD3 1 100% 0% 2 Search MINI+YCD3 Search MINI+YCD3
10 OKT3 THERAPY 1 50% 0% 2 Search OKT3+THERAPY Search OKT3+THERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OKT3 MONOCLONAL ANTIBODY 62 59% 6% 70
2 OKT3 46 30% 11% 131
3 ORTHOCLONE OKT3 31 76% 2% 22
4 CYTOKINE RELATED SYNDROME 19 71% 1% 15
5 TRANSPLANTATION RESPONSES 11 78% 1% 7
6 PROPHYLACTIC OKT3 10 61% 1% 11
7 IMMUNOSUPPRESSIVE PROPERTIES 9 20% 3% 39
8 REJECTION PROPHYLAXIS 8 75% 1% 6
9 ORTHOCLONE OKT3 MONOCLONAL ANTIBODY 8 100% 0% 5
10 ANTI CD3 MONOCLONAL ANTIBODY 7 14% 4% 49

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Muromonab CD3 - A reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection 1996 47 187 71%
Anti-CD3 clinical trials in type 1 diabetes mellitus 2013 16 51 43%
CD3-specific antibody-induced active tolerance: From bench to bedside 2003 164 107 57%
CD3-specific antibodies: a portal to the treatment of autoimmunity 2007 159 94 30%
Anti-CD3 mAbs for treatment of type 1 diabetes 2009 25 51 53%
Anti-CD3 antibodies: towards clinical antigen -specific immunomodulation 2004 19 37 73%
Induction of Immunological Tolerance by Oral Anti-CD3 2012 8 37 46%
CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications 2005 26 52 56%
MUROMONAB CD3 - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL 1989 54 97 69%
MUROMONAB CD-3 - A REVIEW OF ITS PHARMACOLOGY, PHARMACOKINETICS, AND CLINICAL USE IN TRANSPLANTATION 1991 41 55 55%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 UNITE 580 2 44% 0.3% 4
2 AL ESSA ORGAN TRANSPLANT 1 50% 0.1% 1
3 BETH ISRAEL HOSP MED IMMUNOL 1 50% 0.1% 1
4 BIOFARM CELULAS ANIM 1 50% 0.1% 1
5 MED CEDARS SINAI MED PEDIAT 1 50% 0.1% 1
6 MICROBIOL IMMUNOL INTER IMMUNOBIOL 1 50% 0.1% 1
7 NEPHROL HYPERTENSMED 1 50% 0.1% 1
8 PHARMACEUT RD IL 1 50% 0.1% 1
9 RECANATI MILLER TRANSPLANATAT 1 50% 0.1% 1
10 SHANGHAI E 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000263069 BASILIXIMAB//THYMOGLOBULIN//DACLIZUMAB
2 0.0000169193 ANTI CD4 MONOCLONAL ANTIBODY//ANTI ANTIBODIES//ANTI CD4
3 0.0000130525 CD7//SECTM1//RADIAT NUCL MED
4 0.0000098621 T11TS//CD2//CD58
5 0.0000084788 REG REFERENCE IMMUNOGENET TRANSPLANTAT IMMU//GRAFT ISCHEMIC TIME//HLA MATCHMAKER
6 0.0000077228 STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL
7 0.0000074235 TADEUSZ ORLOWSKI//MCGOOGAN LIB MED//ANTIBODY REPLACEMENT THERAPY
8 0.0000071462 NEW STERNHEIMER STAINING//GRAFT INFILTRATING CELLS//EX VIVO PROPAGATION
9 0.0000061262 LYMPHOCYTOTOXIC CROSSMATCH//ANNETTE C HAROLD C SIMMONS TRANSPLANT//LIVER ALLOGRAFT REJECTION
10 0.0000060122 CYCLOSPORINE G//CYCLOSPORINE METABOLITES//CYCLOSPORIN G